Publicaciones en colaboración con investigadores/as de Massachusetts General Hospital (36)

2023

  1. GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors

    American Journal of Psychiatry

  2. Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations

    Nature genetics, Vol. 55, Núm. 3, pp. 369-376

2022

  1. Identifying the Common Genetic Basis of Antidepressant Response

    Biological Psychiatry Global Open Science, Vol. 2, Núm. 2, pp. 115-126

  2. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

  3. Sex-Dependent Shared and Nonshared Genetic Architecture Across Mood and Psychotic Disorders

    Biological Psychiatry, Vol. 91, Núm. 1, pp. 102-117

2021

  1. A Comparison of Ten Polygenic Score Methods for Psychiatric Disorders Applied Across Multiple Cohorts

    Biological Psychiatry, Vol. 90, Núm. 9, pp. 611-620

  2. Association of polygenic score for major depression with response to lithium in patients with bipolar disorder

    Molecular Psychiatry, Vol. 26, Núm. 6, pp. 2457-2470

  3. Bipolar multiplex families have an increased burden of common risk variants for psychiatric disorders

    Molecular Psychiatry, Vol. 26, Núm. 4, pp. 1286-1298

  4. Correction to: Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality (Molecular Psychiatry, (2020), 25, 10, (2493-2503), 10.1038/s41380-018-0339-3)

    Molecular Psychiatry

  5. Correction: Genome-wide gene-environment analyses of major depressive disorder and reported lifetime traumatic experiences in UK Biobank (Molecular Psychiatry, (2020), 25, 7, (1430-1446), 10.1038/s41380-019-0546-6)

    Molecular Psychiatry

  6. Correction: Investigating rare pathogenic/likely pathogenic exonic variation in bipolar disorder (Molecular Psychiatry, (2021), 26, 9, (5239-5250), 10.1038/s41380-020-01006-9)

    Molecular Psychiatry

  7. Genetic association study of childhood aggression across raters, instruments, and age

    Translational Psychiatry, Vol. 11, Núm. 1

  8. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology

    Nature genetics, Vol. 53, Núm. 6, pp. 817-829

  9. Investigating rare pathogenic/likely pathogenic exonic variation in bipolar disorder

    Molecular Psychiatry, Vol. 26, Núm. 9, pp. 5239-5250

  10. Risk variants and polygenic architecture of disruptive behavior disorders in the context of attention-deficit/hyperactivity disorder

    Nature Communications, Vol. 12, Núm. 1

2020

  1. A phenome-wide association and Mendelian Randomisation study of polygenic risk for depression in UK Biobank

    Nature Communications, Vol. 11, Núm. 1

  2. Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality

    Molecular Psychiatry, Vol. 25, Núm. 10, pp. 2493-2503

  3. Classical Human Leukocyte Antigen Alleles and C4 Haplotypes Are Not Significantly Associated With Depression

    Biological Psychiatry, Vol. 87, Núm. 5, pp. 419-430

  4. Genome-wide gene-environment analyses of major depressive disorder and reported lifetime traumatic experiences in UK Biobank

    Molecular Psychiatry, Vol. 25, Núm. 7, pp. 1430-1446

  5. Shared genetic background between children and adults with attention deficit/hyperactivity disorder

    Neuropsychopharmacology, Vol. 45, Núm. 10, pp. 1617-1626